China Respiratory Devices Market Growth, Opportunities 2031

China Respiratory Devices Market Growth, Opportunities 2031

Segments - China Respiratory Devices Market by Types (Diagnostic & Monitoring Devices [Pulse Oximeter, Sleep Test Devices, Spirometers, Capnographs, Peak Flow Meters, and Others], Therapeutic Devices [BiPAP Devices, Inhalers, Nebulizers, CPAP Devices, Humidifiers, Ventilators, Oxygen Concentrators, and Others], and Disposables [Breathing Circuits, Masks, and Others]), and End-users (Home Care, Hospitals, and Ambulatory Care Centers)–Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1565 | 4.4 Rating | 82 Reviews | 192 Pages | Format : PDF Excel PPT

Report Description


China Respiratory Devices Market Outlook 2031:

The china respiratory devices market size was valued at USD 2.62 Billion in 2022 and is projected to reach USD 4.82 Billion by 2031, expanding at a CAGR of 7% during the forecast period 2023 - 2031The respiratory devices supply respiratory air automatically to people with reduced respiratory concern. The respiratory gas is usually enhanced by oxygen and delivered inside the lung with a certain pressure created in the device.

The ventilator fully affects pressures and volumes. While in aided respiration the respiratory device simply provides the mechanical breathing attempts with an established overpressure.

China Respiratory Devices Market Outlook

The Covid-19 pandemic affected the demand and supply of China respiratory devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing investments by hospitals is projected to boost the market in the coming years.
  • Introduction of technological and novel advanced products is the major factor fueling the market.
  • Emerging economies and lack of health infrastructure is anticipated to restrict the market growth.
  • Lack of awareness about respiratory devices present a main challenge that can hamper the market expansion during the forecast period.
  • R&D investment and technological advancement in respiratory devices market is projected to offer lucrative opportunities for the market players.

Scope of the China Respiratory Devices Market Report

The report on the China respiratory devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

China Respiratory Devices Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Types (Diagnostic & Monitoring Devices [Pulse Oximeter, Sleep Test Devices, Spirometers, Capnographs, Peak Flow Meters, and Others], Therapeutic Devices [BiPAP Devices, Inhalers, Nebulizers, CPAP Devices, Humidifiers, Ventilators, Oxygen Concentrators, and Others], and Disposables [Breathing Circuits, Masks, and Others]), End-users (Home Care, Hospitals, and Ambulatory Care Centres)

Country

China

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Vincent Medical; Medtronic PLC; GlaxoSmithKline PLC; Fisher & Paykel Healthcare Ltd; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Koninklijke Philips NV; and ResMed Inc.  

China Respiratory Devices Market Segment Insights

The therapeutic devices segment accounts for key share of the market

Based on types, the China respiratory devices market is divided into diagnostic & monitoring devices, therapeutic devices, and disposables. The diagnostic & monitoring spirometers devices segment are sub-segmented into pulse oximeter, sleep test devices, spirometers, capnographs, peak flow meters, and others.

The therapeutic devices segment is sub-segmented into BiPAP devices, inhalers, nebulizers, CPAP devices, humidifiers, ventilators, oxygen concentrators, and others.  The disposables segment is sub-segmented into breathing circuits, masks, and others. The therapeutic devices accounts for a key share of the market. Growth of the market is attributed to technological advancement in healthcare sector and increasing per capita income.

However, the diagnostic & monitoring devices segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising demand for respiratory devices in private hospitals and increasing availability of trained professionals.

China Respiratory Devices Market Types

The hospitals segment accounts for significant share of the market

On the basis of end-users, the market is categorized into home care, hospitals, and ambulatory care centres. The hospital segment accounts for a significant share of the market. Growth of the market attributed to increasing prevalence of respiratory disorders and rapid advancement in respiratory devices.

The ambulatory care centres segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing demand for inhalers and rapid urbanization.

China Respiratory Devices Market End User

Segments

The China respiratory devices market has been segmented on the basis of

Types

  • Diagnostic and Monitoring Devices

    • Pulse Oximeter
    • Sleep Test Devices
    • Spirometers
    • Capnographs
    • Peak Flow Meters
    • Others
  • Therapeutic Devices

    • BiPAP Devices
    • Inhalers
    • Nebulizers
    • CPAP Devices
    • Humidifiers
    • Ventilators
    • Oxygen Concentrators
    • Others
  • Disposables

    • Breathing Circuits
    • Masks
    • Others

End-users

  • Home Care
  • Hospitals
  • Ambulatory Care Centers

Country

  • China

Key Players

  • Vincent Medical
  • Medtronic PLC
  • GlaxoSmithKline PLC
  • Fisher & Paykel Healthcare Ltd
  • DeVilbiss Healthcare LLC
  • GE Healthcare
  • Dragerwerk AG
  • Koninklijke Philips NV
  • ResMed Inc. 

Competitive Landscape

Key players competing in the China respiratory devices market include Vincent Medical; Medtronic PLC; GlaxoSmithKline PLC; Fisher & Paykel Healthcare Ltd; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Koninklijke Philips NV; and ResMed Inc. 

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to
generate revenue and rise their production line of the business in the coming years.

China Respiratory Devices Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Respiratory Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Respiratory Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Respiratory Devices Market - Supply Chain
  4.5. Global Respiratory Devices Market Forecast
     4.5.1. Respiratory Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Respiratory Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Respiratory Devices Market Absolute $ Opportunity
5. Global Respiratory Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Respiratory Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Respiratory Devices Demand Share Forecast, 2019-2026
6. North America Respiratory Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Respiratory Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Respiratory Devices Demand Share Forecast, 2019-2026
7. Latin America Respiratory Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Respiratory Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Respiratory Devices Demand Share Forecast, 2019-2026
8. Europe Respiratory Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Respiratory Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Respiratory Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Respiratory Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Respiratory Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Respiratory Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Respiratory Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Respiratory Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Respiratory Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Respiratory Devices Market: Market Share Analysis
  11.2. Respiratory Devices Distributors and Customers
  11.3. Respiratory Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Vincent Medical
     11.4.2. Medtronic PLC
     11.4.3. GlaxoSmithKline PLC
     11.4.4. Fisher & Paykel Healthcare Ltd
     11.4.5. DeVilbiss Healthcare LLC

Methodology

Our Clients

Honda Motor Co. Ltd.
sinopec
General Electric
Siemens Healthcare
Nestle SA
Microsoft
FedEx Logistics
Pfizer